GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FullHope Biomedical Co Ltd (ROCO:7773) » Definitions » Additional Paid-In Capital

FullHope Biomedical Co (ROCO:7773) Additional Paid-In Capital : NT$241.51 Mil(As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FullHope Biomedical Co Additional Paid-In Capital?


FullHope Biomedical Co's quarterly additional paid-in capital declined from Dec. 2023 (NT$438.22 Mil) to Jun. 2024 (NT$202.18 Mil) but then increased from Jun. 2024 (NT$202.18 Mil) to Dec. 2024 (NT$241.51 Mil).

FullHope Biomedical Co's annual additional paid-in capital increased from Dec. 2022 (NT$19.18 Mil) to Dec. 2023 (NT$438.22 Mil) but then declined from Dec. 2023 (NT$438.22 Mil) to Dec. 2024 (NT$241.51 Mil).


FullHope Biomedical Co Additional Paid-In Capital Historical Data

The historical data trend for FullHope Biomedical Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FullHope Biomedical Co Additional Paid-In Capital Chart

FullHope Biomedical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
4.96 19.18 438.22 241.51

FullHope Biomedical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial 19.18 - 438.22 202.18 241.51

FullHope Biomedical Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

FullHope Biomedical Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of FullHope Biomedical Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


FullHope Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
Lane 609, Sector. 5, Chongxin Road, 10th Floor, No. 10, Sanchong District, New Taipei City, TWN
FullHope Biomedical Co Ltd focuses on immune system-related services and innovative R&D. It establishes cell-based immunotherapies for cancers and autoimmune disorders. Its services are, Immunoprofiling, Circulating Tumor Cells Testing, Regulation of Cell Therapy, Contracting Immune Cell Manufacturing, Immune Cell Bank, Contract Research Organization, and Endotoxin and Mycoplasma Detection Service.

FullHope Biomedical Co Headlines

No Headlines